Related Experiment Video
Updated: Apr 20, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy
Michelle N Messmer1, Colleen S Netherby, Debarati Banik
1Department of Immunology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263, USA.
Cancer disrupts immune balance, favoring abnormal myeloid cells over lymphoid responses. Restoring myeloid differentiation may enhance anti-tumor immunity and serve as a biomarker for disease status.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Immune homeostasis requires a balance between lymphoid and myeloid responses.
- Neoplasia often leads to an imbalance, characterized by expanded immature myeloid cells and diminished lymphoid responses.
- This immune dysregulation impacts cancer progression and treatment efficacy.
Purpose of the Study:
- To define atypical myelopoiesis in cancer patients and its clinical impact.
- To investigate the mechanisms driving these myeloid alterations.
- To explore strategies for restoring myeloid differentiation and enhancing anti-tumor immunity.
Main Methods:
- This review synthesizes current research on myeloid cell differentiation in cancer.
- It examines clinical data correlating myeloid abnormalities with outcomes.
- Mechanistic insights are drawn from preclinical and clinical studies.
Main Results:
- Atypical myelopoiesis is a common feature in cancer, associated with poor clinical outcomes.
- Neoplastic processes fundamentally alter myeloid homeostasis.
- These alterations impair the host's anti-tumor immune response.
Conclusions:
- Dysregulated myeloid differentiation in cancer is a critical factor influencing therapeutic efficacy.
- Restoring normal myeloid cell differentiation presents a promising therapeutic strategy.
- Myeloid cell alterations can serve as novel biomarkers for disease monitoring.
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Differentiation of Common Myeloid Progenitor Cells
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against...

